Methode de l'Allaitement Maternel et de l'Amenorrhee (MAMA)

American Academy of Pediatrics, Committee on Drugs. 1994. The transfer of drugs and other chemicals into human breastmilk. Pediatrics 93: 137.  

Anderson P. 1991. Drug use during breastfeeding. Clinical Pharmacology 10: 595-624.  

Organisation mondiale de la santé (OMS). 1992. Consensus Statement from the WHO/UNICEF Consultation of HIV Transmission and Breastfeeding. OMS: Genèva, 30 avril-1^er mai.  

Organisation mondiale de la santé (OMS). 1986. Guidelines Concerning the Main Health and Socio-Economic Circumstances in Which Infants Have to Be Fed on Breastmilk Substitutes. OMS, Trente-neuvième assemblée mondiale sur la sante, 10 avril.

Contraceptifs Oraux Combines

American College of Obstetricians and Gynecologists. 1992. Safety of oral contraceptives for teenagers. International Journal of Gynaecology and Obstetrics 37: 309-312.  

Bracken MB. 1990. Oral contraceptive and congenital malformations in offspring: A review and meta-analysis of the prospective studies. Obstetrics and Gynecology 76: 552-557.  

Brinton LA. 1991. Oral contraceptives and cervical neoplasia. Contraception 43(6): 581-595.  

Collaborative Group for the Study of Stroke in Young Women. 1975. Oral contraceptives and stroke in young women. JAMA 231: 718-722.  

Curry S et al. 1989. Hormonal contraception and trophoblastic sequelae after hydatidiform mole. American Journal of Obstetrics and Gynecology 160(4): 805-811.  

Daewood MY. 1993. Considerations in selecting appropriate medical therapy for endometriosis. International Journal of Gynaecology and Obstetrics 40 Suppl: 529-542.  

Dahlman T et al. 1985. Changes in blood coagulation and fibrinolysis in the normal puerperium. Gynecologic and Obstetric Investigation 20(1): 37-44.  

Diana JN. 1990. Tobacco smoking and atherosclerosis in Tobacco Smoking and Atherosclerosis, Diana JN (ed), 1-7. Plenum Press: New York.  

Diccas R et al. 1991. The role of contraception in the development of postmolar gestational trophoblastic tumor. Obstetrics and Gynecology 78(2): 221-226.  

Dyken M et P Wolf. 1984. Risk factors in stroke. A statement for physicians by the Subcommittee on Risk Factors and Stroke of the Stroke Council. Stroke 15: 1105-1111.  

Fisch I et J Frank. 1977. Oral contraceptives and blood pressure. JAMA 237: 2499-2503.  

Godsland I et VC Wynn. 1990. Low dose oral contraceptive and carbohydrate metabolism. American Journal of Obstetrics and Gynecology 163: 348-353.  

Huggins G et P Zucker. 1987. Oral contraceptives and neoplasia: 1987 update. Fertility and Sterility 47: 733-761.  

Kaplowitz N et al. 1986. Drug-induced hepatotoxicity. Annals of Internal Medicine 104: 826-839.  

Organisation mondiale de la santé (OMS). OMS Collaborative Study of Cardiovascular Disease and the Use of Steroid Hormone Contraceptives. Hemorrhagic stroke and the combined oral contraceptive: Results of an international multicentre case-control study. (non-publié).  

Organisation mondiale de la santé (OMS) Task Force on Oral Contraceptives. 1989. The OMS multicentre trial of the vasopressor effects of combined oral contraceptives: comparisons with IUD. Contraception 40: 129-145.  

Organisation mondiale de la santé (OMS) Task Force on Oral Contraceptives. 1988. Special Programme on Research, Development and Research Training in Human Reproduction. Effects of hormonal contraceptives on breast milk composition and infant growth. Studies in Family Planning 19(6): 361-369.  

Organisation mondiale de la santé (OMS) Task Force on IUDs for Fertility Regulation. 1985. A multinational case-control study of ectopic pregnancy. Clinical Reproduction and Fertility 3: 131-143.  

Organisation mondiale de la santé (OMS) Task Force on Oral Contraceptives. 1984. Effects of hormonal contraceptives on milk volume and infant growth. Contraception 30: 505-521.  

Orme MLE et al. 1993. Drug interactions with oral contraceptive steroids. 19-26.  

Rivera R et al. 1983. The effects of three different regimens of oral contraceptives and three different intrauterine devices on the levels of hemoglobin, serum iron and iron binding capacity in anemic women. Contraception 27(3): 311-327.  

Samside G. 1994. Coagulation and anticoagulation effects of contraceptive steroids. American Journal of Obstetrics and Gynecology 170: 1523-1527.  

Schepps B et al. 1994. Benign circumscribed breast masses, mammographic and sonographic appearance. Obstetrics and Gynecology Clinics of North America 21(s): 519-537.  

Schesselman JJ. 1991. Oral contraceptives and neoplasia of the uterine corpus. Contraception 43(6): 557-579.  

Shinton R et G Beevers. 1989. Meta-analysis of relationship between cigarette smoking and stroke. British Medical Journal 298: 789-794.  

Simpson J et O Phillips. 1990. Spermicides, hormonal contraception and congenital malformations. Advances in Contraception 6: 141-147.  

Stanfrod JL. 1991. Oral contraceptives and neoplasia of the ovary. Contraception 43(6): 543-556.  

Thomas DB. 1991. Oral contraceptives and breast cancer: Review of the epidemiological literature. Contraception 43(6): 597-642.  

Thus C et P Knipschild. 1993. Oral contraceptives and the risk of gallbladder disease. A meta-analysis. American Journal of Public Health 83: 1113-1120.  

US Department of Health and Human Services. 1983. The Health Consequences of Smoking: Cardiovascular Disease: A Report of the Surgeon General. US Department of Health and Human Services. Public Health Services, Office of the Secretary of Health, Office on Smoking and Health. JHHS Publication No. 84: 50204.  

Vessy M et Painter R. 1994. Oral contraceptive use and benign gallbladder disease: Revisited. Contraception 50: 167-173.  

Wolner H et al. 1990. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA 263: 54-59.

Contraceptifs Injectables Combines

American College of Obstetricians and Gynecologists. 1992. Safety of oral contraceptives for teenagers. International Journal of Gynecology and Obstetrics 37: 309-312.  

Bracken MB. 1990. Oral contraceptive and congenital malformations in offspring: A review and meta-analysis of the prospective studies. Obstetrics and Gynecology 76: 552-557.  

Brinton LA. 1991. Oral contraceptives and cervical neoplasia. Contraception 43(6): 581-595.  

Dahlman T et al. 1985. Changes in blood coagulation and fibrinolysis in the normal puerperium. Gynecologic and Obstetric Investigation 20(1): 37-44.  

Diana JN. 1990. Tobacco smoking and atherosclerosis, in Tobacco Smoking and Atherosclerosis, Diana JN (ed), 1-7. Plenum Press: New York.  

Fraser JS. 1994. Vaginal bleeding patterns in women using once-a-month injectable contraceptives. Contraception 49: 399-420.  

Organisation mondiale de la santé (OMS) Task Force on Oral Contraceptives. Special Programme on Research, Development and Research Training in Human Reproduction. 1988. Effects of hormonal contraceptives on breast milk composition and infant growth. Studies in Family Planning 19(6): 361-369.  

Organisation mondiale de la santé (OMS) Task Force on Oral Contraceptives. 1984. Effects of hormonal contraceptives on milk volume and infant growth. Contraception 30: 505-521.  

Schepps B et al. 1994. Benign circumscribed breast masses, mammographic and sonographic appearance. Obstetrics and Gynecology Clinics of North America 21(s): 519-537.  

Shinton R et G Beevers. 1989. Meta-analysis of relationship between cigarette smoking and stroke. British Medical Journal 298: 789-794.  

Simpson J et O Phillips. 1990. Spermicides, hormonal contraception and congenital malformations. Advances in Contraception 6: 141-147.  

Speroff J et al. 1989. Clinical Gynecologic Endocrinology and Infertility, 4th edition. Williams & Wilkins: Baltimore, Maryland.  

Thomas DB. 1991. Oral contraceptives and breast cancer: review of the epidemiological literature. Contraception 43(6): 597-642.  

US Department of Health and Human Services. 1983. The Health Consequences of Smoking: Cardiovascular Disease. A Report of the Surgeon General. US Department of Health and Human Services, Public Health Services, Office of the Secretary of Health, Office on Smoking and Health. JHHS Publication No. 84: 50204.

Contraceptifs a Seul Progestatif

Belsey EM. 1991. Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on long-acting systemic agents for fertility regulation. Advances in Contraception 7(2-3): 257-270.  

Benson M et R Rebar. 1986. Relationship of migraine headache and stroke to oral contraceptive use. Journal of Reproductive Medicine 31(12): 1082-1088.  

Bracken MB. 1990. Oral contraceptive and congenital malformations in offspring: A review and meta-analysis of the prospective studies. Obstetrics and Gynecology 76: 552-557.  

Deceulaer K et al. 1982. Medroxyprogesterone acetate and homozygous sickle-cell disease. Lancet 1: 229-231.  

Faundes A et al. 1987. Subjective perception of bleeding and serum ferritin concentration in long-term users of Norplant. Contraception 35(2): 189-196.  

Fotherby K. 1989. The progestin-only pill and thrombosis. British Journal of Family Planning 15: 83-85.  

Fraser I et E Weisberg. 1981. A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. The Medical Journal of Australia Special Suppl: 1-20.  

Ladipo DA et al. 1993. Norplant use by women with sickle cell disease. International Journal of Gynaecology and Obstetrics 41: 85-87.  

Mattson R et R Rebar. 1993. Contraceptive methods for women with neurologic disorders. American Journal of Obstetrics and Gynecology 168: 2027-2032.  

McCann M et L Potter. 1994. Progestin-only oral contraception. Contraception 50(6 Suppl): S9-S195.  

Mishell DR. 1991. Long-acting contraceptive steroids, dans Infertility, Contraception and Reproductive Endocrinology, Mitchell DR, Davajan V et Lobo RA (eds). Blackwell Scientific Publications: Boston, Massachusetts.  

Norplant^®. 1990. Levonorgestrel Implants: A summary of scientific data. The Population Council: New York.  

Organisation mondiale de la santé (OMS). Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Long-Acting Systematic Agents for Fertility Regulation. 1993. A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users. Contraception 47(2): 177-191.  

Organisation mondiale de la santé (OMS). Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives. 1988. Effects of hormonal contraceptives on breast milk composition and infant growth. Studies in Family Planning 19(6): 361-369.  

Organisation mondiale de la santé (OMS). 1983. Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Long-acting Agents for the Regulation of Fertility. Multinational comparative clinical trial of long-acting injectable contraceptives: Norethisterone enanthate given in two dosage regimens and depotmedroxyprogesterone acetate. Final report. Contraception 28(1): 1-20.  

Pardthaisong G et al. 1992. The long-term growth and development of children exposed to Depo-Provera during pregnancy and lactation. Contraception 45: 313-324.  

Schepps B et al. 1994. Benign circumscribed breast masses, mammographic and sonographic appearance. Obstetrics and Gynecology Clinics of North America 21(s): 519-537.  

Simpson J et O Phillips. 1990. Spermicides, hormonal contraception and congenital malformations. Advances in Contraception 6: 141-147.  

Speroff L et P Darney. 1992. A Clinical Guide for Contraception. Williams & Wilkins: Baltimore, Maryland.  

Speroff J et al. 1989. Clinical Gynecologic Endocrinology and Infertility, 4th edition. Williams & Wilkins: Baltimore, Maryland.  

Thomas DB. 1991. Oral contraceptives and breast cancer: Review of the epidemiological literature. Contraception 43(6): 597-642.

Dispositifs Intra-Uterins

Allonen H. 1994. The Levonorgestrel IUD dans Proceedings from the Fourth International Conference on IUDs, Bardin CW et DR Mishell (eds). Butterworth Heinemann. 284-292.  

Anderson K et G Rybo. 1987. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology 97: 690-694.  

Andrade A et E Pizarro. 1987. Quantitative studies on menstrual blood loss in IUD users. Contraception 36(1): 129-144.  

Farley T et al. 1992. Intrauterine devices and pelvic inflammatory disease: An international perspective. Lancet 339: 785-788.  

Heikkila M et al. 1982. Levonorgestrel in milk and plasma of breastfeeding women with a levonorgestrel-releasing IUD. Contraception 25: 41-49.  

Heikkila M et al. 1982. Immediate postabortal insertion of Levonorgestrel-releasing IUD. Contraception 25: 245-259.  

Heikkila M et T Luukkainen. 1982. Duration of breast-feeding and development of children after insertion of a Levonorgestrel-releasing intrauterine contraceptive device. Contraception 25: 279-292.  

Indian Council of Medical Research Task Force on IUD. 1989. Randomized clinical trial with intrauterine devices (Levonorgestrel intrauterine device (LNG), CuT 380 Ag, CuT 220C and CuT 200B). A 36-month study. Contraception 39: 37-52.  

Petersen K et al. 1991. Intrauterine devices in nulliparous women. Advances in Contraception 7(4): 333-338.  

Scarselli G et al. 1988. Levonorgestrel-Nova-T and precancerous lesions of the endometrium. European Journal of Gynaecologic Oncology 9: 284-286.  

Shikary Z et al. 1987. Transfer of levonorgestrel (LNG) administered through different drug delivery systems from the maternal circulation into the newborn infant's circulation via breast milk. Contraception 35: 477-486.  

Sivin I et al. 1991. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20mcg/day (LNG 20) and the copper T380 Ag IUDs. Contraception 44: 473-480.  

Toivonen J et al. 1991. Protective effect of intrauterine release of levonorgestrel on pelvic infection. Three years comparative experience of levonorgestrel- and copper-releasing intrauterine devices. Obstetrics and Gynecology 77: 261-264.

Methodes Barrieres

Centers for Disease Control. 1988. Condoms for the prevention of sexually transmitted diseases. MMWR 37: 133-137.  

Centers for Disease Control and Prevention. 1993. Update: barrier protection against HIV infection and other sexually transmitted diseases. MMWR 42: 589-597.  

Hooten T et al. 1991. Escherichia coli bacteriaria and contraceptive method. JAMA 265: 64-69.  

Roody R et al. 1993. A dosing study of nonoxynol-9 and genital irritation. International Journal of STDs/AIDS 4: 165-170.  

Schwartz B et al. 1989. Toxic Shock Study Group. Reviews of Infectious Diseases 11S1: S42-S48.  

Stone K et al. 1986. Primary prevention of sexually transmitted diseases. JAMA 255(13): 1763-1766.  

Trussell J et al. 1993. Contraceptive efficacy of the diaphragm, the sponge and the cervical cap. Family Planning Perspectives 25: 100-105, 135.  

Turjanmas K et T Keunala. 1989. Condoms as a source of latex allergen and cause of contact urticaria. Contact Dermatitis 20: 360-364.

Planification Familiale Naturelle et coit Interrompu

Organisation mondiale de la santé (OMS). 1988. Natural family planning: A guide to provision of services. OMS: Genèva.  

Rogow D et S Horowitz. 1993. Withdrawal is a choice: a review of the literature and an agenda for research on coitus interruptus. IWHC Monograph.  

Santow G. 1991. Coitus interruptus in the twentieth century. Population and Development Review 19: 767-792.  

Shoupe D et al. 1991. Infertility, Contraception and Reproductive Endocrinology, 3rd ed. Boston, Mass.

Sterilisation Volontaire

Carlton C et P Scardino. 1986. Initial evaluation, including history, physical examination, and urinalysis dans Campbell's Urology, 5th ed, Walsh PC et al (eds), 276-285. W.B. Saunders Co.: Philadelphia, Pennsylvania.  

Carson J et al. 1988. Severity of anemia and operative mortality and morbidity. Lancet 1: 727-729.  

Chi I et al. 1985. Interval tubal sterilization in obese women--an assessment of risks. American Journal of Obstetrics and Gynecology 152: 292-297.  

Chi I et al. 1983. Previous abdominal surgery as a risk factor in interval laparscopic sterilization. American Journal of Obstetrics and Gynecology 145: 841-846.  

Cohn I et G Bornside. 1989. Infections, dans Principles of Surgery, 5th ed. Schwartz SI, GT Shires et FC Spencer (eds.), McGraw-Hill Book Co.: New York. 181-215.  

Diettrich N et al. 1991. A growing spectrum of surgical disease in patients with human immunodeficiency virus/acquired immunodeficiency syndrome. Archives of Surgery 126(7): 860-865.  

Estafanous FG. 1989. Hypertension in the surgical patient: Management of blood pressure and anesthesia. Cleveland Clinic Journal of Medicine. 56: 385-393.  

Howards SS. 1986. Surgery of the scrotum and its contents, dans Campbell's Urology, 5th ed, Walsh PC et al (eds), 663-664. WB Saunders Co.: Philadelphia, Pennsylvania.  

Jonsson K et al. Tissue oxygenation, anemia, and perfusion in relation to wound healing in surgical patients. Annals of Surgery 214: 605-613.  

Murphy AA. 1992. Diagnostic and operative laparoscopy, dans Te Linde's Operative Gynecology, 7th ed, Thompson JD et A Rockfj (eds). JB Lippincott Co.: Philadelphia, Pennsylvania.  

Pastorek J et C White. 1988. Surgical sterilization at the time of cesarean delivery. Obstetrics and Gynecology Clinics of North America. 15: 771-781.  

Roizen MF. 1990. Anesthetic complications of concurrent disease, dans Anesthesia, 3rd ed. Miller RD (ed), 793-893. Churchill Livingstone: New York.  

Schwartz SI. 1989. Complications, dans Principles of Surgery, 5th ed, Schwartz SI, GT Shires et FC Spencer (eds), 470. McGraw-Hill Book Company: New York.  

Schwartz SI. 1989. Hemostasis, surgical bleeding, and transfusion, dans Principles of Surgery, 5th ed, Schwartz SI, GT Shires and FC Spencer (eds), 121-122. McGraw-Hill Book Company: New York.